1.UNAIDS. AIDSinfo http://aidsinfo.unaids.org/ (accessed May 2, 2019). 2018.
2.Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. The Lancet Infectious Diseases. 2016;16(6):e92-e107.
3.le Roux SM, Abrams EJ, Donald KA, Brittain K, Phillips TK, Nguyen KK, et al. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study. The Lancet Child & Adolescent Health. 2019;3(4):234-44.
4.Le Roux SM, Abrams EJ, Nguyen K, Myer L. Clinical outcomes of HIV‐exposed, HIV‐uninfected children in sub‐Saharan Africa. Tropical Medicine & International Health. 2016;21(7):829-45.
5.Moseholm E, Helleberg M, Sandholdt H, Katzenstein TL, Storgaard M, Pedersen G, et al. Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life—A Danish Nationwide Cohort. Clinical Infectious Diseases. 2019.
6.Powis KM, Smeaton L, Hughes MD, Tumbare EA, Souda S, Jao J, et al. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. AIDS (London, England). 2016;30(2):211.
7.Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. Journal of acquired immune deficiency syndromes (1999). 2011;56(2):131.
8.Ramokolo V, Goga AE, Lombard C, Doherty T, Jackson DJ, Engebretsen IM. In Utero ART Exposure and Birth and Early Growth Outcomes Among HIV-Exposed Uninfected Infants Attending Immunization Services: Results From National PMTCT Surveillance, South Africa. Open Forum Infectious Diseases. 2017;4(4).
9.Rosala-Hallas A, Bartlett JW, Filteau S. Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age. BMC pediatrics. 2017;17(1):80.
10.Zash R, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, et al. Comparative safety of antiretroviral treatment regimens in pregnancy. JAMA pediatrics. 2017;171(10):e172222-e.
11.Dadabhai S, Gadama L, Chamanga R, Kawalazira R, Katumbi C, Makanani B, et al. Pregnancy outcomes in the era of universal antiretroviral treatment in sub-Saharan Africa (POISE Study). JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019;80(1):7-14.
12.le Roux SM, Donald KA, Brittain K, Phillips TK, Zerbe A, Nguyen KK, et al. Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa. Aids. 2018;32(13):1781-91.
13.Malaba TR, Phillips T, Le Roux S, Brittain K, Zerbe A, Petro G, et al. Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women. International journal of epidemiology. 2017;46(5):1678-89.
14.Moodley T, Moodley D, Sebitloane M, Maharaj N, Sartorius B. Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa. BMC pregnancy and childbirth. 2016;16(1):35.
15.Santosa WB, Staines-Urias E, Tshivuila-Matala CO, Norris SA, Hemelaar J. Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa. Aids. 2019;33(10):1623-33.
16.Woldesenbet SA, Kufa T, Barron P, Ayalew K, Cheyip M, Chirombo BC, et al. Assessment of readiness to transition from antenatal HIV surveillance surveys to PMTCT programme data-based HIV surveillance in South Africa: The 2017 Antenatal Sentinel HIV Survey. International Journal of Infectious Diseases. 2020;91:50-6.
17.Slogrove AL, Becquet R, Chadwick EG, Côté HC, Essajee S, Hazra R, et al. Surviving and thriving—shifting the public health response to HIV-exposed uninfected children: Report of the 3rd HIV-exposed uninfected child workshop. Frontiers in pediatrics. 2018;6:157.
18.Myer L, Phillips T, Manuelli V, McIntyre J, Bekker L-G, Abrams EJ. Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. Journal of acquired immune deficiency syndromes (1999). 2015;69(2):e57.
19.National Department of Health. The 2015 National Antenatal Sentinel HIV & Syphilis Survey, South Africa
2017.
20.Paul A. Harris RT, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G. Conde. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;14(2):377-81.
21.Villar J, Ohuma E, Stirnemann J, Papageorghiou A, Kennedy S. Clarification of INTERGROWTH-21st newborn birthweight standards–Authors' reply. The Lancet. 2018;391(10134):1996.
22.World Health Organization. AUDIT: The alcohol use disorders identification test: Guidelines for use in primary health care. World Health Organization; 2001.
23.StataCorp. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC. 2017.
24.Hofer CB, Keiser O, Zwahlen M, Lustosa CS, CisneFrota AC, de Oliveira RH, et al. In utero exposure to antiretroviral drugs: effect on birth weight and growth among HIV-exposed uninfected children in Brazil. The Pediatric infectious disease journal. 2016;35(1):71.
25.Newell M-L, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Current Opinion in HIV and AIDS. 2013;8(5):504-10.
26.Slogrove AL, Clayden P, Abrams EJ. Towards a Universal Antiretroviral Regimen: Special Considerations of Pregnancy and Breast Feeding. Current Opinion in HIV and AIDS. 2017;12(4):359.